Skip to content

Solid Biosciences Inc. SLDB Interest coverage

Interest coverage at other companies

Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
101×+77.4×
Insmed logo
InsmedINSM
-14×+3.9×
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
-45.3×
Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
-2,501.2×-6,679×
uniQure logo
uniQureQURE
-3.1×+0.6×
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
-84.7×

Other financials

Income statement

See full
Revenue$2.0M-40.6%
Operating income-$57.3M-43.1%
Net income-$56.7M-44.4%
EPS (diluted)-$0.52+11.9%

Balance sheet

See full
Cash & equivalents$297.1M+41.1%
Total debt$20.7M-12.5%
Total equity$374.1M+27.1%
Total assets$422.9M+23.0%

Cash flow

See full
Operating cash flow-$47.2M-48.3%
CapEx$165.0K+31.0%
Free cash flow-$47.4M-48.2%

Valuation

See full
Market cap$872.26M+135%
Enterprise value$595.83M+223%
P/S107.8×-9.9×

Profitability

See full
Operating margin-1,315.2%-4,060pp
Net margin-1,062.3%-251,151pp
FCF margin-1,247.7%-9,569pp

Returns & leverage

See full
Return on equity-57.4%+2.2pp
Debt / equity0.1×0.0×
Current ratio13.1×+2.2×

Where this comes from

Calculated from Solid Biosciences Inc.’s reported figures.

Based on trailing twelve months.

The official record: Solid Biosciences Inc.’s 10-Q, filed August 12, 2025, on SEC EDGAR. View the filing →

Ask your AI about Solid Biosciences Inc.'s interest coverage.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Solid Biosciences Inc.'s interest coverage?
Solid Biosciences Inc. (SLDB) reported interest coverage of -550.3× in Q2 2025.
How has Solid Biosciences Inc.'s interest coverage changed year-over-year?
Solid Biosciences Inc.'s interest coverage decreased by 114.5% year-over-year, from -256.5× to -550.3×.
What does interest coverage mean?
Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.